AUPR879501A0 - Novel chemical compounds and their use - Google Patents

Novel chemical compounds and their use

Info

Publication number
AUPR879501A0
AUPR879501A0 AUPR8795A AUPR879501A AUPR879501A0 AU PR879501 A0 AUPR879501 A0 AU PR879501A0 AU PR8795 A AUPR8795 A AU PR8795A AU PR879501 A AUPR879501 A AU PR879501A AU PR879501 A0 AUPR879501 A0 AU PR879501A0
Authority
AU
Australia
Prior art keywords
chemical compounds
novel chemical
compounds
trifluoroacetyl
acetyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPR8795A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biota Scientific Management Pty Ltd
Original Assignee
Biota Scientific Management Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biota Scientific Management Pty Ltd filed Critical Biota Scientific Management Pty Ltd
Priority to AUPR8795A priority Critical patent/AUPR879501A0/en
Publication of AUPR879501A0 publication Critical patent/AUPR879501A0/en
Priority to DK02774169T priority patent/DK1451184T3/da
Priority to HK05100550.7A priority patent/HK1068344B/en
Priority to AT02774169T priority patent/ATE398123T1/de
Priority to KR1020047006445A priority patent/KR100942493B1/ko
Priority to PCT/AU2002/001528 priority patent/WO2003040138A1/en
Priority to US10/494,241 priority patent/US7230028B2/en
Priority to CA2462345A priority patent/CA2462345C/en
Priority to ES02774169T priority patent/ES2305301T3/es
Priority to CNB028222490A priority patent/CN1301993C/zh
Priority to JP2003542184A priority patent/JP5178989B2/ja
Priority to DE60227101T priority patent/DE60227101D1/de
Priority to EP02774169A priority patent/EP1451184B1/en
Priority to PT02774169T priority patent/PT1451184E/pt
Priority to AU2002340635A priority patent/AU2002340635B2/en
Priority to US11/751,269 priority patent/US7795301B2/en
Priority to JP2010161643A priority patent/JP5179546B2/ja
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/55—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AUPR8795A 2001-11-09 2001-11-09 Novel chemical compounds and their use Abandoned AUPR879501A0 (en)

Priority Applications (17)

Application Number Priority Date Filing Date Title
AUPR8795A AUPR879501A0 (en) 2001-11-09 2001-11-09 Novel chemical compounds and their use
AU2002340635A AU2002340635B2 (en) 2001-11-09 2002-11-08 Dimeric compounds and their use as anti-viral agents
ES02774169T ES2305301T3 (es) 2001-11-09 2002-11-08 Compuestos dimericos y su utilizacion como agentes antiviricos.
JP2003542184A JP5178989B2 (ja) 2001-11-09 2002-11-08 二量体化合物および抗ウイルス薬としてのそれらの使用
AT02774169T ATE398123T1 (de) 2001-11-09 2002-11-08 Dimere verbindungen und deren verwendung als antivirale mittel
KR1020047006445A KR100942493B1 (ko) 2001-11-09 2002-11-08 이량체 화합물 및 항바이러스제로서의 그의 용도
PCT/AU2002/001528 WO2003040138A1 (en) 2001-11-09 2002-11-08 Dimeric compounds and their use as anti-viral agents
US10/494,241 US7230028B2 (en) 2001-11-09 2002-11-08 Dimeric compounds and their use as anti-viral agents
CA2462345A CA2462345C (en) 2001-11-09 2002-11-08 Dimeric compounds and their use as anti-viral agents
DK02774169T DK1451184T3 (da) 2001-11-09 2002-11-08 Dimere forbindelser og deres anvendelse som antivirale midler
CNB028222490A CN1301993C (zh) 2001-11-09 2002-11-08 二聚化合物及其作为抗病毒剂的用途
HK05100550.7A HK1068344B (en) 2001-11-09 2002-11-08 Dimeric compounds and their use as anti-viral agents
DE60227101T DE60227101D1 (de) 2001-11-09 2002-11-08 Dimere verbindungen und deren verwendung als antivirale mittel
EP02774169A EP1451184B1 (en) 2001-11-09 2002-11-08 Dimeric compounds and their use as anti-viral agents
PT02774169T PT1451184E (pt) 2001-11-09 2002-11-08 Compostos diméricos e sua utilização como agentes antivirais
US11/751,269 US7795301B2 (en) 2001-11-09 2007-05-21 Dimeric compounds and their use as anti-viral agents
JP2010161643A JP5179546B2 (ja) 2001-11-09 2010-07-16 二量体化合物および抗ウイルス薬としてのそれらの使用

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPR8795A AUPR879501A0 (en) 2001-11-09 2001-11-09 Novel chemical compounds and their use

Publications (1)

Publication Number Publication Date
AUPR879501A0 true AUPR879501A0 (en) 2001-12-06

Family

ID=3832614

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPR8795A Abandoned AUPR879501A0 (en) 2001-11-09 2001-11-09 Novel chemical compounds and their use

Country Status (13)

Country Link
US (2) US7230028B2 (enExample)
EP (1) EP1451184B1 (enExample)
JP (2) JP5178989B2 (enExample)
KR (1) KR100942493B1 (enExample)
CN (1) CN1301993C (enExample)
AT (1) ATE398123T1 (enExample)
AU (1) AUPR879501A0 (enExample)
CA (1) CA2462345C (enExample)
DE (1) DE60227101D1 (enExample)
DK (1) DK1451184T3 (enExample)
ES (1) ES2305301T3 (enExample)
PT (1) PT1451184E (enExample)
WO (1) WO2003040138A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPR879501A0 (en) * 2001-11-09 2001-12-06 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
KR102808936B1 (ko) 2015-11-20 2025-05-15 오스트레일리언 바이오메디컬 컴퍼니 피티와이 리미티드 의학적 용도의 화합물
JP6806171B2 (ja) 2017-02-10 2021-01-06 三菱ケミカル株式会社 導電性組成物、導電性組成物の製造方法及び導電体の製造方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2106301C (en) * 1991-03-18 1999-04-06 Chi-Huey Wong Oligosaccharide enzyme substrates and inhibitors: method and compositions
GB9516276D0 (en) * 1995-08-08 1995-10-11 Biota Scient Management Chemical compounds
IL125662A0 (en) * 1996-03-01 1999-04-11 Biota Scient Management Method of detecting influenza virus and compounds for use therein
AUPP913999A0 (en) * 1999-03-12 1999-04-01 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
AUPR001000A0 (en) * 2000-09-08 2000-10-05 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
AUPR879601A0 (en) * 2001-11-09 2001-12-06 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
AUPR879501A0 (en) * 2001-11-09 2001-12-06 Biota Scientific Management Pty Ltd Novel chemical compounds and their use

Also Published As

Publication number Publication date
JP2005511610A (ja) 2005-04-28
JP5178989B2 (ja) 2013-04-10
CA2462345A1 (en) 2003-05-15
HK1068344A1 (en) 2005-04-29
CN1301993C (zh) 2007-02-28
JP2011006424A (ja) 2011-01-13
US7795301B2 (en) 2010-09-14
EP1451184A1 (en) 2004-09-01
KR100942493B1 (ko) 2010-02-12
KR20050044338A (ko) 2005-05-12
US20070225359A1 (en) 2007-09-27
US7230028B2 (en) 2007-06-12
ATE398123T1 (de) 2008-07-15
DK1451184T3 (da) 2008-10-27
ES2305301T3 (es) 2008-11-01
JP5179546B2 (ja) 2013-04-10
WO2003040138A1 (en) 2003-05-15
DE60227101D1 (de) 2008-07-24
CA2462345C (en) 2011-10-18
CN1585767A (zh) 2005-02-23
EP1451184B1 (en) 2008-06-11
US20050043399A1 (en) 2005-02-24
PT1451184E (pt) 2008-09-17
EP1451184A4 (en) 2005-02-02

Similar Documents

Publication Publication Date Title
AU7535798A (en) Novel cyclosporin derivatives, preparation and pharmaceutical compositions containing same
AU5669298A (en) Cyclosporin derivatives, their preparation and pharmaceutical compositions containing them
HUP0101999A2 (hu) 4-Hidroxi-kinolin-3-karboxamid- és -hidrazid-származékok, ezeket tartalmazó gyógyászati készítmények, valamint e vegyületek alkalmazása
PL367682A1 (en) Dolastatin 10 derivatives
AU5669398A (en) Novel cyclosporin derivatives, method of preparation and pharmaceutical compositions containing them
AR035927A1 (es) Compuesto de lactama (n)-((s)-2-hidroxi-3-metilbutiril)-1-(l-alaninil)-(s)-1-amino-3-metil-4,5,6,7-tetrahidro-2h-3-benzazepin-2-ona , composicion farmaceutica que lo comprende, procedimiento para la inhibicion de la liberacion de peptido b-amiloide y/o su sintesis que lo emplea y su uso para la fabr
WO1998056761A3 (en) Benzimidazole derivatives
MY141661A (en) 17b-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
DZ3312A1 (fr) Compositions pharmaceutiques contenant des derives d'azetidine, les nouveaux derives d'azetidine et leur preparation
CA2400268A1 (en) Pyrrolopyrimidinone derivatives, process of preparation and use
HUP0202570A1 (hu) Izoflavonokat és analogonjait tartalmazó készítmények és terápiás alkalmazásuk
ZA200110540B (en) Novel diphenyl-piperidine derivate.
GB0104050D0 (en) Chemical compounds
MD1560F2 (en) Cyclic compounds, pharmaceutical compositions on base thereof and methods of treatment of infections or diseases provoked by retroviruses.
AU7270798A (en) Antithrombotic agents
WO2002072581A3 (en) Pyrazolopyriadine derivatives
EP1451184A4 (en) DIMERE COMPOUNDS AND THEIR USE AS ANTIVIRAL AGENTS
BR9306870A (pt) Derivados farmacologicamente ativos de (aminometila terciária) - benzenometanol
AU2003263455A1 (en) Pyrazole amides for treating hiv infections
AUPR879401A0 (en) Novel chemical compounds and their use
MXPA04003738A (es) Composiciones farmaceuticas que contienen macrolidos.
ATE301997T1 (de) Antivirale therapie
AU4485101A (en) Antiviral therapy
GB0223234D0 (en) Chemical compounds
PL374919A1 (en) Novel indoline compound and medicinal use thereof